FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116744620> ?p ?o ?g. }

• W2116744620 endingPage "638" @default.
• W2116744620 startingPage "627" @default.
• W2116744620 abstract "Squamous cell carcinoma of the head and neck (SCCHN) is one of the most common malignancies worldwide, with low 5-year survival rates. Current strategies that block epidermal growth factor receptor (EGFR) have limited effects when administered as single agents. Targeting EGFR via intratumoral administration of phosphorothioate-modified antisense oligonucleotides has antitumor efficacy in xenograft models of SCCHN. Because intratumoral delivery of therapeutic agents has limited clinical application, the present study was undertaken to examine the therapeutic mechanisms of systemically delivered phosphorothioate-modified EGFR antisense oligonucleotides alone, or in combination with docetaxel, in a SCCHN xenograft model. EGFR antisense oligonucleotides were administered at 5 mg/kg i.p. daily in athymic mice bearing 1483 human SCCHN xenografts alone or in combination with docetaxel at 2.5 mg/kg i.p. once a week for 4 weeks. Administration of EGFR antisense oligonucleotides in combination with docetaxel improved antitumor efficacy and resulted in lower expression levels of EGFR, fewer proliferating cells, and more apoptotic cells in the tumors compared with controls. Systemic administration of phosphorothioated EGFR antisense oligonucleotides for 30 days increased the retention of docetaxel in the tumor by approximately 4-fold compared with tumors treated with docetaxel alone or docetaxel and EGFR sense oligonucleotides (P < 0.05). Combination of EGFR antisense oligonucleotides with low doses of docetaxel has antitumor efficacy, and it may be an effective treatment strategy for SCCHN." @default.
• W2116744620 created "2016-06-24" @default.
• W2116744620 creator A5015532170 @default.
• W2116744620 creator A5017526826 @default.
• W2116744620 creator A5066378974 @default.
• W2116744620 creator A5076365167 @default.
• W2116744620 creator A5085654922 @default.
• W2116744620 creator A5088102524 @default.
• W2116744620 creator A5088286120 @default.
• W2116744620 creator A5089153048 @default.
• W2116744620 date "2007-11-19" @default.
• W2116744620 modified "2023-09-27" @default.
• W2116744620 title "Antitumor Mechanisms of Systemically Administered Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck" @default.
• W2116744620 cites W1603230122 @default.
• W2116744620 cites W1765857451 @default.
• W2116744620 cites W1966672421 @default.
• W2116744620 cites W1968785826 @default.
• W2116744620 cites W1977340600 @default.
• W2116744620 cites W1977887541 @default.
• W2116744620 cites W1999311530 @default.
• W2116744620 cites W2000433012 @default.
• W2116744620 cites W2017788990 @default.
• W2116744620 cites W2029176206 @default.
• W2116744620 cites W2038443998 @default.
• W2116744620 cites W2051183427 @default.
• W2116744620 cites W2060606238 @default.
• W2116744620 cites W2065656306 @default.
• W2116744620 cites W2084303847 @default.
• W2116744620 cites W2085145451 @default.
• W2116744620 cites W2112443004 @default.
• W2116744620 cites W2145115983 @default.
• W2116744620 cites W2153534791 @default.
• W2116744620 cites W2153991063 @default.
• W2116744620 cites W2155384808 @default.
• W2116744620 cites W2181479067 @default.
• W2116744620 cites W2290539832 @default.
• W2116744620 cites W4255169631 @default.
• W2116744620 doi "https://doi.org/10.1124/mol.107.041160" @default.
• W2116744620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18025070" @default.
• W2116744620 hasPublicationYear "2007" @default.
• W2116744620 type Work @default.
• W2116744620 sameAs 2116744620 @default.
• W2116744620 citedByCount "11" @default.
• W2116744620 countsByYear W21167446202012 @default.
• W2116744620 countsByYear W21167446202013 @default.
• W2116744620 countsByYear W21167446202015 @default.
• W2116744620 countsByYear W21167446202016 @default.
• W2116744620 countsByYear W21167446202017 @default.
• W2116744620 crossrefType "journal-article" @default.
• W2116744620 hasAuthorship W2116744620A5015532170 @default.
• W2116744620 hasAuthorship W2116744620A5017526826 @default.
• W2116744620 hasAuthorship W2116744620A5066378974 @default.
• W2116744620 hasAuthorship W2116744620A5076365167 @default.
• W2116744620 hasAuthorship W2116744620A5085654922 @default.
• W2116744620 hasAuthorship W2116744620A5088102524 @default.
• W2116744620 hasAuthorship W2116744620A5088286120 @default.
• W2116744620 hasAuthorship W2116744620A5089153048 @default.
• W2116744620 hasConcept C121608353 @default.
• W2116744620 hasConcept C126322002 @default.
• W2116744620 hasConcept C129312508 @default.
• W2116744620 hasConcept C143998085 @default.
• W2116744620 hasConcept C185592680 @default.
• W2116744620 hasConcept C2776530083 @default.
• W2116744620 hasConcept C2776694085 @default.
• W2116744620 hasConcept C2776833033 @default.
• W2116744620 hasConcept C2776999253 @default.
• W2116744620 hasConcept C2779438470 @default.
• W2116744620 hasConcept C2779998722 @default.
• W2116744620 hasConcept C2781190966 @default.
• W2116744620 hasConcept C502942594 @default.
• W2116744620 hasConcept C526805850 @default.
• W2116744620 hasConcept C552990157 @default.
• W2116744620 hasConcept C55493867 @default.
• W2116744620 hasConcept C71924100 @default.
• W2116744620 hasConcept C98274493 @default.
• W2116744620 hasConceptScore W2116744620C121608353 @default.
• W2116744620 hasConceptScore W2116744620C126322002 @default.
• W2116744620 hasConceptScore W2116744620C129312508 @default.
• W2116744620 hasConceptScore W2116744620C143998085 @default.
• W2116744620 hasConceptScore W2116744620C185592680 @default.
• W2116744620 hasConceptScore W2116744620C2776530083 @default.
• W2116744620 hasConceptScore W2116744620C2776694085 @default.
• W2116744620 hasConceptScore W2116744620C2776833033 @default.
• W2116744620 hasConceptScore W2116744620C2776999253 @default.
• W2116744620 hasConceptScore W2116744620C2779438470 @default.
• W2116744620 hasConceptScore W2116744620C2779998722 @default.
• W2116744620 hasConceptScore W2116744620C2781190966 @default.
• W2116744620 hasConceptScore W2116744620C502942594 @default.
• W2116744620 hasConceptScore W2116744620C526805850 @default.
• W2116744620 hasConceptScore W2116744620C552990157 @default.
• W2116744620 hasConceptScore W2116744620C55493867 @default.
• W2116744620 hasConceptScore W2116744620C71924100 @default.
• W2116744620 hasConceptScore W2116744620C98274493 @default.
• W2116744620 hasIssue "3" @default.
• W2116744620 hasLocation W21167446201 @default.
• W2116744620 hasLocation W21167446202 @default.
• W2116744620 hasOpenAccess W2116744620 @default.
• W2116744620 hasPrimaryLocation W21167446201 @default.

• next